Summary
Highlights
Fertilization typically occurs in the fallopian tube, with the embryo developing for 5-6 days before reaching the uterus. In IVF, this process is meticulously replicated in a lab under precise conditions, despite which about 50% of fertilized eggs may not reach the blastocyst stage.
PGT is a testing method used before embryo implantation to check for genetic abnormalities. PGTA screens for age-related chromosomal abnormalities, while PGTM (for monogenetic diseases like cystic fibrosis) and PGTSR (for structural rearrangements) address specific genetic conditions. PGT involves taking 5-8 cells from the placental portion of the embryo, with results typically available in two weeks.
Embryo transfers are usually done with frozen embryos (FET), which involves preparing the uterus with a medicated or natural cycle. Success rates with genetically normal embryos are high: 65% for one transfer, 86% for two, and 95% for three transfers. However, a single embryo doesn't guarantee a baby, and multiple IVF rounds might be necessary for extended family planning, especially as age affects egg quality.
A patient couple, both carriers of Spinal Muscular Atrophy (SMA), underwent IVF with PGTM testing. Despite genetic predictions, a high number of embryos were affected, requiring multiple IVF cycles to obtain enough suitable embryos. This highlights the importance of preconception genetic screening and planning for family goals.
IVF and genetic testing are often not covered by insurance. The video argues that genetic testing empowers couples to plan for healthy children and emphasizes that it's more complex than simply 'designer babies'. Patients need to advocate for themselves, find a good clinic, and understand the process to manage expectations. IVF is a complex medical process, not a guaranteed outcome.